11ß-HSD1 and Metabolic Syndrome

计划入组 24 人 · 首次发布于 2006 年 8 月 31 日

Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor

计划入组 43 人 · 首次发布于 2017 年 6 月 7 日

TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma

计划入组 33 人 · 首次发布于 2017 年 9 月 26 日

11beta-HSD1 inhibitors (Galderma)

11-beta-HSD1 inhibitors (Schering-Plough)

11-beta HSD1 inhibitors (Scottish Biomedical)

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

Sparrow Pharmaceuticals Bets Cortisol, Not GLP-1, Is the Next Frontier in Type 2 Diabetes

Emestedastat Shows Late-Emerging Antidepressant Signal in Difficult-to-Treat MDD Despite Missing Cognitive Endpoint

Actinogen's Xanamem (Emestedastat) Receives WHO Recognition and Advances in Alzheimer's Trials